Costunolide Enhances Radiosensitivity in Liver Cancer Cells
Author Information
Author(s): Liu Chia-Yuan, Chang Hsun-Shuo, Chen Ih-Sheng, Chen Chih-Jen, Hsu Ming-Ling, Fu Shu-Ling, Chen Yu-Jen
Primary Institution: Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan
Hypothesis
Does costunolide induce mitotic arrest and enhance radiosensitivity in human hepatocellular carcinoma cells?
Conclusion
Costunolide reduces cell viability and arrests cell cycling at mitosis in hepatoma cells, enhancing the effectiveness of radiotherapy.
Supporting Evidence
- Costunolide reduced the viability of HA22T/VGH cells.
- It caused a rapid G2/M arrest at 4 hours.
- Costunolide-treated cells were arrested at mitosis, not G2 phase.
- The sensitizer enhancement ratio was up to 1.9.
- Costunolide up-regulated several proteins related to mitosis.
Takeaway
Costunolide is a natural compound that helps cancer cells stop dividing, making them more sensitive to radiation treatment.
Methodology
The study used cell viability assays, cell cycle analysis, flow cytometry, immunofluorescence, Western blotting, and clonogenic assays.
Limitations
The study primarily focused on one cell line and did not explore effects on normal liver cells in detail.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website